A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
119
Journal Issue
3
Pages
674-684
Date Issued
2020-03
Author(s)
Li, Yi-Heng
Chen, Jaw-Wen
Wang, Yu-Chen
Yeh, Hung-I
Huang, Chin-Chou
Chang, Kuan-Cheng
Chen, Po-Wei
Huang, Chen-Wei
Chen, Zhih-Cherng
Chang, Wei-Ting
Huang, Wei-Chun
Lee, Mei-Yueh
Chao, A-Ching
Fu, Wei-Ren
Chan, Hsin-Lung
Yang, Yi-Ching
Abstract
Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.
Subjects
Atherosclerosis; Performance guide; Risk factors
SDGs
Publisher
ELSEVIER TAIWAN
Type
review